March 16, 2020 / 12:17 PM / 19 days ago

BRIEF-Aimmune Announces First U.S. Patients Are Being Treated With Newly-Approved Palforzia, The First Treatment For Peanut Allergy

March 16 (Reuters) - Aimmune Therapeutics Inc:

* AIMMUNE ANNOUNCES FIRST U.S. PATIENTS ARE BEING TREATED WITH NEWLY-APPROVED PALFORZIA™, THE FIRST TREATMENT FOR PEANUT ALLERGY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below